Rh Sensitization During PregnancyExams and TestsIf you are pregnant, you will have your first prenatal tests during
your first
trimester. At your first prenatal visit, every woman
has her blood tested to see what her blood type is. If your blood is
Rh-negative, it will also be tested for
antibodies to Rh-positive blood. If you have
antibodies, that means that you have been
sensitized to Rh-positive blood. The antibodies can
now kill Rh-positive red blood cells. If you are Rh-negative and your partner is Rh-positive,
your
fetus is likely to be Rh-positive. If you are pregnant or have
miscarried, or if you have had an elective abortion, a
partial molar pregnancy, or an
ectopic pregnancy, you will need testing to see if you
have been sensitized to Rh-positive blood. If you are Rh-negativeAll pregnant women have an
indirect Coombs' test during early pregnancy. - At the first prenatal visit, your blood is
tested to see if you have been previously sensitized to Rh-positive blood. If
you are Rh-negative and test results show that you are not sensitized, a repeat
test may be done between 24 and 28 weeks.
- If test results at 28
weeks show that you have not been sensitized, no additional tests for
Rh-related problems are done until delivery (barring complications such as
placenta abruptio). You will also have a shot of Rh
immune globulin. This lowers your chances of being sensitized during the last
weeks of your pregnancy.
- If your newborn is found to be
Rh-positive, your blood will be screened again at delivery with an indirect
Coombs' test to see if you have been sensitized during late pregnancy or
childbirth. If you have not been sensitized, you will have another shot of Rh
immune globulin.
If you are sensitized to the Rh factorIf you are already Rh-sensitized or become sensitized while
pregnant, close monitoring is important to determine whether your fetus is
being harmed. - An
indirect Coombs' test is done periodically during your
pregnancy to see if your Rh-positive antibody levels are increasing. This is
the typical course of treatment for most sensitized women during
pregnancy.
- Fetal
Doppler ultrasound of blood flow in the brain shows
fetal anemia and how bad it is. At a medical center with Doppler experts, this
test can give you the same anemia information as
amniocentesis, without the risks.4
- Amniocentesis may be done:
- At or after 15 weeks to check
amniotic fluid for signs of fetal problems.
- To learn the fetal
blood type and Rh factor.
- On a repeated
basis to check fetal anemia. This tells how much a fetus is being affected by
sensitization.
- Fetal blood sampling (cordocentesis) may be done to
directly assess your fetus's health. This procedure is used on a limited basis,
usually for monitoring known sensitization problems (as when a mother has had
previous fetal deaths, or when other testing has shown signs of fetal
distress).
- Electronic fetal heart monitoring
(nonstress test) may be done in the third trimester to check your fetus's
condition. Unusual fetal heart rhythms detected during a nonstress test may be
a sign that the fetus has
anemia related to the sensitization.
- Fetal ultrasound testing can be used as a pregnancy
progresses to detect sensitization problems, such as fetal fluid retention (a
sign of severe Rh disease).
Early DetectionEarly prenatal Rh blood typing and testing for Rh sensitization
is necessary to ensure that every vulnerable fetus can be properly monitored
and treated.
Go to previous section | Go to top of page | Go to next section |
| | Author: | Kathe Gallagher, MSW | Last Updated: November 2, 2007 | | Medical Review: | Joy Melnikow, MD, MPH - Family Medicine Gregory A L Davies, MD, FRCSC, FACOG - Maternal-Fetal Medicine | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |